Dr. Li is responsible for the overall management, business strategies, regulatory approvals and commercial suitability and sustainability of products of the Group. Dr. Li has over 22 years of experience in the biopharmaceutical industry, and he was the former senior engineer in the research and development department in Genentech and the former senior scientist in Amgen.
Mr. Liang is responsible for clinical development, operation and management. Mr. Liang has over 21 years of experience in clinical development in China and the United States with strong expertise in medical sciences and biostatistics. He was a former vice president and the general manager for ICON Greater China, a former vice president and the general manager for WuXi Clinical, and a former senior director and general manager for Quintiles Dalian Center of Excellence.
Dr. Li is responsible for antibody discovery and development. Dr. Li has over 14 years of experience in the research and biopharmaceutical industry. She was a former associate professor for National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences and a former associate professor for Shanghai Institute for Advanced Immunochemical Studies (SIAIS), ShanghaiTech University.
Dr. Liu is responsible for pharmacology, translational medicine and regulatory affairs. Dr. Liu has over 21 years of experience in the biopharmaceutical industry, and she was a former scientist and senior scientist at Gilead, Genentech and Tanox.
Chairman of the Board and General Manager
Director /Chief Medical Officer and Deputy General Manager
Director/Deputy General Manager
(Antibody Discovery and Development)
Deputy General Manager
(Translational Medicine and Regulatory Affairs)
